Thomas J. Wilson
Keine laufenden Positionen mehr
Profil
Mr. Thomas J.
Wilson is Vice President-Quality Assurance at Synta Pharmaceuticals Corp.
Mr. Wilson was previously employed as a Director-Quality & Analytical by Euthymics Bioscience, Inc., a Principal by Granutec, Inc., and a Principal by Mallinckrodt Animal Health, Inc.
He received his undergraduate degree from Truman State University and a graduate degree from Kansas State University.
Ehemalige bekannte Positionen von Thomas J. Wilson
Unternehmen | Position | Ende |
---|---|---|
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 06.06.2011 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Granutec LLC
Granutec LLC Industrial MachineryProducer Manufacturing Granutec LLC manufactures granulator machines and auxiliary equipment. The firm’s granulators include auger-matic granulators, tangential feed and central granulators. It offers a selection of in-house designed and manufactured auxiliary machines, including heavy duty blowers and cyclones, and metal detector systems. The company was founded by Merritt Tetreault in 1980 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Mallinckrodt Animal Health, Inc. | Corporate Officer/Principal | - |
Ausbildung von Thomas J. Wilson
Kansas State University | Graduate Degree |
Truman State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Granutec LLC
Granutec LLC Industrial MachineryProducer Manufacturing Granutec LLC manufactures granulator machines and auxiliary equipment. The firm’s granulators include auger-matic granulators, tangential feed and central granulators. It offers a selection of in-house designed and manufactured auxiliary machines, including heavy duty blowers and cyclones, and metal detector systems. The company was founded by Merritt Tetreault in 1980 and is headquartered in Rockville, MD. | Producer Manufacturing |
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Mallinckrodt Animal Health, Inc. |